Is NeOnc Technologies Holdings, Inc. Common Stock (NTHI) overvalued? · rev $40.0K
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a biotechnology company listed on NASDAQ.
This page asks whether NeOnc Technologies Holdings, Inc. Common Stock (NTHI) looks expensive on cached numbers — not a short thesis.
Latest reported NTHI revenue for 2025-12-31 was $40.0K. Net income was -$62.1M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. NTHI currently screens at market cap $117.3M.
NTHI currently screens at market cap $117.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NTHI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NTHI stock page for the full model, not this heading.
Not investment advice.